Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer. [electronic resource]
Producer: 19891130Description: 1995-2000 p. digitalISSN:- 0008-543X
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Agranulocytosis -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Heart -- drug effects
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Myocardium -- pathology
- Prospective Studies
- Random Allocation
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.